Dave Sharp
Person
The scientist who nominated Rapamycin for the Interventions Testing Program, recognizing its potential for cancer and aging even before widespread mTor research.
Mentioned in 2 videos
Save the 2 videos on Dave Sharp to your own pod.
Sign up free to keep building your knowledge base on Dave Sharp as more episodes are added.
Videos Mentioning Dave Sharp
#148 - Richard Miller, M.D., Ph.D.: The gold standard for testing longevity drugs: the ITP
Peter Attia MD
A colleague of Randy Strong and an expert on mTOR, who suggested Rapamycin as an ITP candidate based on invertebrate data.
222 ‒ How nutrition impacts longevity | Matt Kaeberlein, Ph.D.
Peter Attia MD
The scientist who nominated Rapamycin for the Interventions Testing Program, recognizing its potential for cancer and aging even before widespread mTor research.